Brief: Allergy Therapeutics Announces Positive Interim Analysis Data From Phase I/Iia Vlp Peanut Protect Trial
04/12/2024 07:18
Dec 4 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS PLC: ANNOUNCES POSITIVE INTERIM
ANALYSIS
DATA FROM PHASE I/IIA VLP PEANUT PROTECT TRIAL
Source text: ID:nRSD6783Oa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update